Advertising disclosure — We may earn a commission if you start care through some of these links, at no extra cost to you. How we're funded. Order reflects our editorial rubric and our commercial relationships; scores are ours alone.
Head-to-head for women
MEDGm vs MyDrHank
MEDGm and MyDrHank both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.
MEDGm
Ranked #68 for women · Grade C
Luna Fit
Best for: Women who want to know which pharmacies fill the prescription before they start, and who will turn down the twelve-month plan once they read what renewing it costs.
Visit MEDGmMyDrHank
Higher scoreRanked #49 for women · Grade C
Luna Fit
Best for: Readers treating insulin resistance who want tirzepatide at a price that does not climb with the dose, and who will open the plan selector and pay the month-to-month rate rather than the advertised one.
Visit MyDrHankThe verdict for women
MyDrHank edges out MEDGm on the Luna Fit Score, 73 to 68 (C vs C). Readers treating insulin resistance who want tirzepatide at a price that does not climb with the dose, and who will open the plan selector and pay the month-to-month rate rather than the advertised one. The reasoning behind that number is in our MyDrHank write-up for women.
MEDGm is still a genuine option — names all four dispensing pharmacies with addresses and phone numbers, then hides the price behind a sixteen-screen intake. A $179 first month renews at $299, on a page whose own FAQ promises the price never increases. Weigh the six women's-health factors below against your own priorities; the MEDGm scorecard goes through each of them, and if neither of these two is the one, the alternatives to MEDGm we rank for women widens the field.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | MEDGm | MyDrHank |
|---|---|---|
| Luna Fit Score | 68/100 · C | 73/100 · C |
| Overall rank | #68 | #49 |
| Semaglutide | $299/mo month-to-month injection ($179 the first month only, on a coupon applied automatically); prepay $249, $219 or $169 a month on three, six or twelve months billed upfront | $259/mo month-to-month (from $178/mo on a 12-month prepay, $2,140 up front) — the site displays only the prepay rate |
| Tirzepatide | $399/mo month-to-month injection ($279 first month only); prepay $349, $319 or $269 a month on three, six or twelve months billed upfront | $349/mo month-to-month (from $240/mo on a 12-month prepay, $2,883 up front) — the site displays only the prepay rate |
| Coverage | All 50 states and DC, matching its own intake selector | No state list published; its affiliate terms exclude Kansas, Louisiana, Mississippi, New Mexico, North Dakota and West Virginia |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Luna Fit
MEDGm
Ranked #68 · Grade C
What we like
- Names all four dispensing pharmacies with street addresses and phone numbers — RedRock, Health Warehouse, Precision Medicine and Triad Rx
- States the 503A and 503B classes and names the prescribing entities: seven OpenLoop professional corporations and Reliant MD
- Coverage is fifty states and DC in the terms and in the intake selector, with no contradiction between the two
The caveats
- No price appears until a sixteen-screen intake ending in name, email and phone number is finished
- The advertised $179 is a first-month coupon rate; the standing figure is $299, and removing the coupon rewrites the panel on the spot
- The treatments FAQ promises the price never increases, on the same page where a month-to-month plan rises from $179 to $299 at the first renewal
Luna Fit
MyDrHank
Ranked #49 · Grade C
What we like
- Tirzepatide is a first-class option here, not an upsell — the dual GIP/GLP-1 agonist is the one most readers arriving on insulin-resistance questions ask about by name
- The price does not move with the dose: its GLP-1 FAQ states "the price stays the same at every dose — no surprise price increases", so a titration to a higher dose does not re-price the plan
- Prices are published before any intake quiz — the full four-rung ladder for every product, with the up-front total beside each per-month figure, rather than a number you have to qualify for
The caveats
- Every price the site displays is the TWELVE-MONTH PREPAY rate — the renderer takes the cheapest rung of the ladder — so the month-to-month figures ($349 tirzepatide, $259 semaglutide) are shown on no page at all
- Its own footnote advertises a tirzepatide price that exists at no tier: "Plans start at $171/mo for compounded semaglutide and $200/mo for compounded tirzepatide" — $200 appears exactly once in the entire site bundle and no tirzepatide rung costs it; the $171 in the same sentence is the ORAL product's yearly rate, while injectable semaglutide's is $178
- The GLP-1 FAQ calls a prepaid annual rate a plan with "no contract", which is true of the paperwork and misleading about the money
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Neither MEDGm nor MyDrHank is only worth comparing with the other. MEDGm is also written up against CoreAge Rx, 25 points apart on the Luna Fit Score — see MEDGm against CoreAge Rx, factor by factor. MyDrHank is also written up against CoreAge Rx, 20 points apart — see MyDrHank against CoreAge Rx, factor by factor.
- MEDGm vs CoreAge Rx
- MEDGm vs Enhance MD
- MEDGm vs Eden
- MyDrHank vs yourEra
- MyDrHank vs Sesame Care
- MyDrHank vs HealthRX
Or browse the full comparison hub.